TNFα increases tyrosine hydroxylase expression in human monocytes
Abstract Most, if not all, peripheral immune cells in humans and animals express tyrosine hydroxylase (TH), the rate limiting enzyme in catecholamine synthesis. Since TH is typically studied in the context of brain catecholamine signaling, little is known about changes in TH production and function...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-021-00201-x |
id |
doaj-806b43b093964f069d4b1c251c749341 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Adithya Gopinath Martin Badov Madison Francis Gerry Shaw Anthony Collins Douglas R. Miller Carissa A. Hansen Phillip Mackie Malú Gámez Tansey Abeer Dagra Irina Madorsky Adolfo Ramirez-Zamora Michael S. Okun Wolfgang J. Streit Habibeh Khoshbouei |
spellingShingle |
Adithya Gopinath Martin Badov Madison Francis Gerry Shaw Anthony Collins Douglas R. Miller Carissa A. Hansen Phillip Mackie Malú Gámez Tansey Abeer Dagra Irina Madorsky Adolfo Ramirez-Zamora Michael S. Okun Wolfgang J. Streit Habibeh Khoshbouei TNFα increases tyrosine hydroxylase expression in human monocytes npj Parkinson's Disease |
author_facet |
Adithya Gopinath Martin Badov Madison Francis Gerry Shaw Anthony Collins Douglas R. Miller Carissa A. Hansen Phillip Mackie Malú Gámez Tansey Abeer Dagra Irina Madorsky Adolfo Ramirez-Zamora Michael S. Okun Wolfgang J. Streit Habibeh Khoshbouei |
author_sort |
Adithya Gopinath |
title |
TNFα increases tyrosine hydroxylase expression in human monocytes |
title_short |
TNFα increases tyrosine hydroxylase expression in human monocytes |
title_full |
TNFα increases tyrosine hydroxylase expression in human monocytes |
title_fullStr |
TNFα increases tyrosine hydroxylase expression in human monocytes |
title_full_unstemmed |
TNFα increases tyrosine hydroxylase expression in human monocytes |
title_sort |
tnfα increases tyrosine hydroxylase expression in human monocytes |
publisher |
Nature Publishing Group |
series |
npj Parkinson's Disease |
issn |
2373-8057 |
publishDate |
2021-07-01 |
description |
Abstract Most, if not all, peripheral immune cells in humans and animals express tyrosine hydroxylase (TH), the rate limiting enzyme in catecholamine synthesis. Since TH is typically studied in the context of brain catecholamine signaling, little is known about changes in TH production and function in peripheral immune cells. This knowledge gap is due, in part, to the lack of an adequately sensitive assay to measure TH in immune cells expressing lower TH levels compared to other TH expressing cells. Here, we report the development of a highly sensitive and reproducible Bio-ELISA to quantify picogram levels of TH in multiple model systems. We have applied this assay to monocytes isolated from blood of persons with Parkinson’s disease (PD) and to age-matched, healthy controls. Our study unexpectedly revealed that PD patients’ monocytes express significantly higher levels of TH protein in peripheral monocytes relative to healthy controls. Tumor necrosis factor (TNFα), a pro-inflammatory cytokine, has also been shown to be increased in the brains and peripheral circulation in human PD, as well as in animal models of PD. Therefore, we investigated a possible connection between higher levels of TH protein and the known increase in circulating TNFα in PD. Monocytes isolated from healthy donors were treated with TNFα or with TNFα in the presence of an inhibitor. Tissue plasminogen activator (TPA) was used as a positive control. We observed that TNFα stimulation increased both the number of TH+ monocytes and the quantity of TH per monocyte, without increasing the total numbers of monocytes. These results revealed that TNFα could potentially modify monocytic TH production and serve a regulatory role in peripheral immune function. The development and application of a highly sensitive assay to quantify TH in both human and animal cells will provide a novel tool for further investigating possible PD immune regulatory pathways between brain and periphery. |
url |
https://doi.org/10.1038/s41531-021-00201-x |
work_keys_str_mv |
AT adithyagopinath tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes AT martinbadov tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes AT madisonfrancis tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes AT gerryshaw tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes AT anthonycollins tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes AT douglasrmiller tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes AT carissaahansen tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes AT phillipmackie tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes AT malugameztansey tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes AT abeerdagra tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes AT irinamadorsky tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes AT adolforamirezzamora tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes AT michaelsokun tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes AT wolfgangjstreit tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes AT habibehkhoshbouei tnfaincreasestyrosinehydroxylaseexpressioninhumanmonocytes |
_version_ |
1721283094728671232 |
spelling |
doaj-806b43b093964f069d4b1c251c7493412021-07-25T11:30:02ZengNature Publishing Groupnpj Parkinson's Disease2373-80572021-07-017111510.1038/s41531-021-00201-xTNFα increases tyrosine hydroxylase expression in human monocytesAdithya Gopinath0Martin Badov1Madison Francis2Gerry Shaw3Anthony Collins4Douglas R. Miller5Carissa A. Hansen6Phillip Mackie7Malú Gámez Tansey8Abeer Dagra9Irina Madorsky10Adolfo Ramirez-Zamora11Michael S. Okun12Wolfgang J. Streit13Habibeh Khoshbouei14Department of Neuroscience, University of Florida, Center for Translational Research in Neurodegenerative Disease, Norman Fixel Institute for Neurological DiseasesDepartment of Neuroscience, University of Florida, Center for Translational Research in Neurodegenerative Disease, Norman Fixel Institute for Neurological DiseasesDepartment of Neuroscience, University of Florida, Center for Translational Research in Neurodegenerative Disease, Norman Fixel Institute for Neurological DiseasesDepartment of Neuroscience, University of Florida, Center for Translational Research in Neurodegenerative Disease, Norman Fixel Institute for Neurological DiseasesDepartment of Neuroscience, University of Florida, Center for Translational Research in Neurodegenerative Disease, Norman Fixel Institute for Neurological DiseasesDepartment of Neuroscience, University of Florida, Center for Translational Research in Neurodegenerative Disease, Norman Fixel Institute for Neurological DiseasesDepartment of Neuroscience, University of Florida, Center for Translational Research in Neurodegenerative Disease, Norman Fixel Institute for Neurological DiseasesDepartment of Neuroscience, University of Florida, Center for Translational Research in Neurodegenerative Disease, Norman Fixel Institute for Neurological DiseasesDepartment of Neuroscience, University of Florida, Center for Translational Research in Neurodegenerative Disease, Norman Fixel Institute for Neurological DiseasesDepartment of Neuroscience, University of Florida, Center for Translational Research in Neurodegenerative Disease, Norman Fixel Institute for Neurological DiseasesEncor Biotechnology Inc.Department of Neurology, University of FloridaDepartment of Neuroscience, University of Florida, Center for Translational Research in Neurodegenerative Disease, Norman Fixel Institute for Neurological DiseasesDepartment of Neuroscience, University of Florida, Center for Translational Research in Neurodegenerative Disease, Norman Fixel Institute for Neurological DiseasesDepartment of Neuroscience, University of Florida, Center for Translational Research in Neurodegenerative Disease, Norman Fixel Institute for Neurological DiseasesAbstract Most, if not all, peripheral immune cells in humans and animals express tyrosine hydroxylase (TH), the rate limiting enzyme in catecholamine synthesis. Since TH is typically studied in the context of brain catecholamine signaling, little is known about changes in TH production and function in peripheral immune cells. This knowledge gap is due, in part, to the lack of an adequately sensitive assay to measure TH in immune cells expressing lower TH levels compared to other TH expressing cells. Here, we report the development of a highly sensitive and reproducible Bio-ELISA to quantify picogram levels of TH in multiple model systems. We have applied this assay to monocytes isolated from blood of persons with Parkinson’s disease (PD) and to age-matched, healthy controls. Our study unexpectedly revealed that PD patients’ monocytes express significantly higher levels of TH protein in peripheral monocytes relative to healthy controls. Tumor necrosis factor (TNFα), a pro-inflammatory cytokine, has also been shown to be increased in the brains and peripheral circulation in human PD, as well as in animal models of PD. Therefore, we investigated a possible connection between higher levels of TH protein and the known increase in circulating TNFα in PD. Monocytes isolated from healthy donors were treated with TNFα or with TNFα in the presence of an inhibitor. Tissue plasminogen activator (TPA) was used as a positive control. We observed that TNFα stimulation increased both the number of TH+ monocytes and the quantity of TH per monocyte, without increasing the total numbers of monocytes. These results revealed that TNFα could potentially modify monocytic TH production and serve a regulatory role in peripheral immune function. The development and application of a highly sensitive assay to quantify TH in both human and animal cells will provide a novel tool for further investigating possible PD immune regulatory pathways between brain and periphery.https://doi.org/10.1038/s41531-021-00201-x |